On March 22nd, Guidepoint Insights will be hosting a series of virtual group meetings featuring KOLs who will dive deeper into the ASCO-GU (Genitourinary Cancers Symposium) 2022 data updates.


Please select the virtual group meetings of interest below.

    Friday, February 18th

    12:00 PM ET - Andrew Armstrong

    • Prostate Cancer and Bladder Cancer | Protein Degradation, mTOR/Akt/PI3K and AR Receptor Pathway Inhibitors, Immunotherapy Approaches | Associate Professor of Medicine at Duke Cancer Institute

    3:00 PM ET - Eric Jonasch

    • Kidney Cancer, Renal Cell Carcinoma | First-Line Metastatic RCC Treatment, Immunotherapy Use, Targeted Therapies | Professor, Department of Genitourinary Medical Oncology for the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center

    Saturday, February 19th

    4:00 PM ET - Scott Tagawa

    • Prostate Cancer, Kidney Cancer, Bladder Cancer | PSMA Radioligand Therapy, PSMA BiTE, Neuroendocrine Targeting, ADCs, Protein Degradation | Professor at Weill Cornell Medical College, New York


    ASCO-GU meetings will not be recorded and transcripts will not be available after the event. To recreate conditions similar to an in-person meeting, this event will be conducted as a Zoom meeting. As such, participants will be able to see/identify each other.